Podcast


Presenter: Dr. Mike Allan Dr. Scott Garrison James McCormack BSc (Pharm) Pharm D

Podcast: BS Medicine Episode #462: Before you lower blood pressure to 120, listen to this podcast
0:00

In episode 462, James and Mike invite Scott Garrison to talk about some important nuances around guideline recommendations and how low we should lower systolic blood pressure. We look in detail at the SPRINT trial and then come up with a reasonable (in our minds) approach to what thresholds we should use. At the conclusion…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here


CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts
program image
March 9, 2026

BS Medicine Episode #618: From Nerve Pain to Knee Pain: Gabapentinoids for osteoarthritis

In episode 618, Mike K and James chat with Émélie Braschi who helps us go over, yet again, the evidence for the use of gabapentinoids. This time it is for…
Listen 0.5 credits available
program image
March 9, 2026

BS Medicine Episode #617: A Whiff of Prevention: Treating Male Partners to Reduce Bacterial Vaginosis Recurrence

In episode 617, Tina and James bring in Caitlin Finley to review the latest trial that attempts to answer the question of does treating male sexual partners of females undergoing…
Listen 0.5 credits available
program image
March 9, 2026

BS Medicine Episode #616: Taking the “ouch” out of IUD insertion: Can topical lidocaine help?

In episode 616, Tina and James discuss the issue around the evidence for using topical anesthetics to reduce the pain associated with IUD insertion. To help with this discussion, we…
Listen 0.5 credits available
June 4, 2021

Presenter(s):

Dr. Mike Allan Dr. Scott Garrison James McCormack BSc (Pharm) Pharm D
June 4, 2021

This content is certified for MainPro+ Credits, log in to access

Presenter(s):

  • Dr. Mike Allan
  • Dr. Scott Garrison
  • James McCormack BSc (Pharm) Pharm D

Spearkers do not have any conflicts of interest to declare.

1. Vidal-Petiot E, Ford I, Greenlaw N, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388(10056):2142-2152.

2. Bohm M, Schumacher H, Teo KK, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085):2226-2237.

3. Lv YB, Gao X, Yin ZX, et al. Revisiting the association of blood pressure with mortality in oldest old people in China: community based, longitudinal prospective study. BMJ. 2018;361:k2158.

4. Delgado J, Bowman K, Ble A, et al. Blood Pressure Trajectories in the 20 Years Before Death. JAMA Intern Med. 2018;178(1):93-99.

5. Lazarus JM, Bourgoignie JJ, Buckalew VM, et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension. 1997;29(2):641-650

6. Group AS, Cushman WC, Evans GW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-1585.

7. Group SR, Wright JT, Jr., Williamson JD, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103-2116.

8. Drawz PE, Pajewski NM, Bates JT, et al. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension. 2017;69(1):42-50.

9. Agarwal R. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT). J Am Heart Assoc. 2017;6(2)

10. Kjeldsen SE, Mancia G. Unobserved automated office blood pressure measurement in the Systolic Blood Pressure Intervention Trial (SPRINT): systolic blood pressure treatment target remains below 140 mmHg. Eur Heart J Cardiovasc Pharmacother. 2016;2(2):79-80.

11. Seidlerova J, Gelzinsky J, Materankova M, Ceral J, Konig P, Filipovsky J. In the aftermath of SPRINT: further comparison of unattended automated office blood pressure measurement and 24-hour blood pressure monitoring. Blood Press. 2018;27(5):256-261.

12. Kjeldsen SE, Mancia G. Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results. J Hypertens. 2019;37(1):6-8.

13. Johnson KC, Whelton PK, Cushman WC, et al. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018;71(5):848-857.

14. Drawz PE, Agarwal A, Dwyer JP, et al. Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice. JAMA Intern Med. 2020.